
Overview
The Aquamantys® System and bipolar sealers feature innovative Transcollation® technology, a combination of radiofrequency (RF) energy and saline that provides hemostatic sealing of soft tissue and bone during surgery.
Aquamantys System and Bipolar Sealers
Medtronic Advanced Energy built the foundation of its early success on innovative products for solid organ procedures. Studies have shown that using Transcollation technology in general surgery procedures provides the following clinical benefits:
- Reduces blood transfusion rates during and after liver resections1
- Reduces the need for renal clamping in partial nephrectomies2
- May reduce the need for other blood management products during or after the procedure1
- May reduce post-operative pancreatic leaks following distal pancreatectomy3
Components of the Aquamantys System
- The Aquamantys System consists of a generator and disposable, single-use handpieces. Medtronic offers innovative Aquamantys handpieces that are specially designed for general surgery, such as the 9.5 XL Bipolar Sealer with cone-shaped electrodes designed to aid in blunt dissection.
General Surgery Procedures for the Aquamantys System
The Aquamantys System is commonly used for these general surgery procedures:
- Liver resection
- Pancreatectomy
- Partial nephrectomy
References
- Geller DA, Tsung A, Maheshwari V et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB 2005; 7:208-213.
- Urena R, Mendez F, Woods M et al. Laparoscopic partial nephrectomy of solid renal masses without Hilar clamping using a monopolar radiofrequency device. J Urology 2004; 171(3):1054-6.
- Blansfield JA, Rapp MM, Chokshi RJ et al. Novel method of stump closure for distal pancreatectomy with a 75% reduction in pancreatic fistula rate. J Gastrointest Surg 2012; 16(3):524-528.
Transcollation Technology
Transcollation technology may occlude vessels up to 1mm in diameter
The Aquamantys System delivers patented Transcollation technology to stop bleeding and reduce blood loss during and after surgery.1,* It has been clinically shown to lower transfusion rates and may reduce the need for other blood management products.1,*
Our patented integration of RF energy and saline delivers controlled thermal energy to tissue. This combination allows the device temperature to stay at approximately 100°C – nearly 200°C less than conventional devices, which produces a tissue effect without the charring associated with other methods.
Surgical Applications for Transcollation Technology
Transcollation technology is commonly used for these procedures:
- Orthopaedic joint replacement
- Orthopaedic oncology
- Spinal surgery
- Solid organ resection
View a 3D animation of Transcollation technology and the Aquamantys System
* Performance has not been specifically established in all procedures.
References
- Geller DA, Tsung A, Maheshwari V et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB 2005; 7:208-213.
Clinical Benefits of the Aquamantys System
The Aquamantys System uses Transcollation technology, which provides broad tissue-surface hemostasis in a rapid and controlled manner. Transcollation technology has been clinically proven to reduce transfusion rates during and after surgery.1,* MedPAR data has shown that reduced transfusion rates may contribute to lower costs for hospitals2 and reduced length of stay for patients.2,**
Clinical Benefits
- Reduces blood transfusions during and after liver resections1
- Reduces the need for renal clamping in partial nephrectomies3
- May reduce the need for other blood management products during or after the procedure1,*
- May reduce post-operative pancreatic leaks following distal pancreatectomy4
* Performance has not been specifically established in all procedures.
** Covance MedPAR report; length of stay has not been specifically correlated with the Aquamantys System.
References
- Geller DA, Tsung A, Maheshwari V et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB 2005; 7:208-213.
- Covance report; 2009 MedPAR database based on ICD-9-CM Codes for 100% of Medicare beneficiaries.
- Urena R, Mendez F, Woods M et al. Laparoscopic partial nephrectomy of solid renal masses without Hilar clamping using a monopolar radiofrequency device. J Urology 2004; 171(3):1054-6.
- Blansfield JA, Rapp MM, Chokshi RJ et al. Novel method of stump closure for distal pancreatectomy with a 75% reduction in pancreatic fistula rate. J Gastrointest Surg 2012; 16(3):524-528.
Economic Value of the Aquamantys System
Detail – Average length of stay and average costs of liver surgery with and without a transfusion2,**,***
Transcollation technology reduces blood loss during surgery and has been shown to reduce the need for other blood management products such as topical hemostats and energy-based devices.1,* Blood transfusions add costs to surgical procedures through both the direct cost of blood products and the associated increase in average length of stay (LOS) as shown in the tables here.2,**
The Aquamantys System has been clinically shown to reduce blood transfusion rates during and after liver resections.1,* Medtronic can help you create a customized economic analysis. Please contact your local sales representative for more information.
* Performance has not been specifically established in all procedures.
** Covance MedPAR report; length of stay has not been specifically correlated with the Aquamantys System.
*** Performance has not been specifically established with the Aquamantys System.
References
- Geller DA, Tsung A, Maheshwari V et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB 2005; 7:208-213.
- Covance report; 2009 MedPAR database based on ICD-9-CM Codes for 100% of Medicare beneficiaries.